Brief: Blue Water Biotech Acquires Six FDA-Approved Drugs

Onconetix

14/06/2023 12:34

June 14 (Reuters) - Blue Water Biotech Inc  BWV.O :
    * BLUE WATER BIOTECH EXPANDS COMMERCIAL PORTFOLIO BY
ACQUIRING SIX
FDA-APPROVED DRUGS ACROSS VARIOUS TREATMENT AREAS
    * BLUE WATER BIOTECH INC - UNDER DEAL TERMS, CO WILL
PURCHASE
WRASER ASSETS FOR TOTAL OF $8.5 MILLION CASH CONSIDERATION
PAYABLE IN THREE TRANCHES
    * BLUE WATER BIOTECH - SIGNING OF ASSET PURCHASE AGREEMENT
WITH
WRASER FOR PURCHASE OF 6 FDA-APPROVED ASSETS ACROSS MULTIPLE
INDICATIONS
    * BLUE WATER BIOTECH INC - WRASER SHALL RECEIVE 1.0 MILLION
RESTRICTED SHARES OF BLUE WATER'S COMMON STOCK ON CLOSING DATE

Source text for Eikon:  ID:nGNX4l7z4Y 
Further company coverage:  BWV.O 

 (reuters.briefs@thomsonreuters.com)